Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly: Results from the cardiovascular health study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 9, 1995, Pages 1269-1279

  Tracy, Russell P ^a   Bovill, Edwin G ^a   Yanez, David ^b   Psaty, Bruce M ^b   Fried, Linda P ^c   Heiss, Gerardo ^d   Lee, Marshal ^e   Polak, Joseph F ^f   Savage, Peter J ^g  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

blood coagulation factors; cardiovascular disease; elderly; risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; DISEASE ASSOCIATION; ECHOGRAPHY; ELECTROCARDIOGRAM; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0029147223     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.9.1269     Document Type: Article

References (70)

1. National Center for Health Statistics. Advance report of final mortality statistics, 1987. Public Health Service. Hyattsville, Md: US Government Printing Office; 1989.
2. Meade T, Brozovic M, Chakrabarti R, Haines A, Imeson J, Mellows S, Miller G, North W, Stirling Y, Thompson S. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1982;2:533-537.
3. Meade T. The epidemiology of haemostatic and other variables in coronary artery disease. In: Verstraete M, Vermylen J, Lijnen H, Arnout J, eds. Thrombosis and Haemostasis 1987. Leuven, Belgium: International Society on Thrombosis and Haemostasis and Leuven University Press; 1987:37-59.
4. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
5. Stone M, Thorp J. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
6. Yarnell J, Baker I, Sweetnam P, Bainton D, O'Brien J, Whitehead P, Elwood P. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 1991;83:836-844.
7. Kannel W, Wolf P, Castelli W, D'Agostino R. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA. 1987;258: 1183-1186.
8. Kannel W, D'Agostino R, Belanger A. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol. 1992;2:457-466.
9. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi M, de Gennes J, Caen J. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study. Haemostasis. 1989;19:83-90.
10. Dalaker K, Hjermann I, Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol. 1985;61:315-322.
11. Dalaker K, Smith P, Arnesen H, Prydz H. Factor VII-phospholipid complex in male survivors of acute myocardial infarction. Acta Med Scand. 1987;222:111-116.
12. Carvalho de Sousa J, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen J. Factor VII hyperactivity in acute myocardial thrombosis: a relation to the coagulation activation. Thromb Res. 1988;51:165-173.
13. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
14. DeWood M, Spores J, Notske R, Mouser L, Burroughs R, Goldens M, Lang H. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303: 897-902.
15. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes: part 2. N Engl J Med. 1992;326:310-318.
16. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes: part 1. N Engl J Med. 1992;326:242-250.
17. Woolf N, Davies M. Interrelationship between atherosclerosis and thrombosis. In: Fuster V, Verstraete M, eds. Thrombosis in Cardiovascular Disorders. Philadelphia, Pa: WB Saunders Co; 1992:41-77.
18. Tracy R, Bovill E. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 1992;116:1307-1312.
19. Tracy R, Bovill E, Fried L, Heiss G, Lee M, Polak J, Psaty B, Savage P. The distribution of coagulation factors VII, VIII and fibrinogen in adults over the age of 65 years: results from the Cardiovascular Health Study. Ann Epidemiol. 1992;2:509-519.
20. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, Psaty B, Robbins J. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164-1179.
21. Fried L, Borhani N, Enright P, Furberg C, Gardin J, Kronmal R, Kuller L, Manolio T, Mittelmark M, Newman A, O'Leary D, Psaty B, Rautaharju P, Tracy R, Weiler P, for the CHS Research Group. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
22. Tell G, Fried L, Hermanson B, Manolio T, Newman A, Borhani N. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:360-368.
23. Psaty B, Lee M, Savage P, Rutan G, German P, Lyles M, Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol. 1992;45:683-692.
24. Bild D, Fitzpatrick A, Fried L, Wong N, Haan M, Lyles M, Bovill E, Polak J, Schultz R, Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the Cardiovascular Health Study. J Am Geriatr Soc. 1993;41:1047-1056.
25. Rutan G, Lind B, Bild D, Kittner S, LaBaw F, Tell G. Hypotension in older adults: the Cardiovascular Health Study. Hypertension. 1992;19:508-519.
26. Psaty B, Furberg C, Kuller L, Borhani N, Rautaharju P, O'Leary D, Bild D, Robbins J, Fried L, Reid C. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: initial findings from the Cardiovascular Health Study. JAMA. 1992;268:1287-1291.
27. Furberg C, Manolio T, Psaty B, Bild D, Borhani N, Newman A, Tabatznik B, Rautaharju P. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol 1992;69:1329-1335.
28. O'Leary D, Polak J, Wolfson S, Bond M, Bommer W, Sheth S, Psaty B, Sharrett A, Manolio T, for the CHS Investigators. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke. 1991;22:1155-1163.
29. Gardin J, Wong N, Bommer W, Klopfenstein H, Smith V, Tabatznik B, Siscovic D, Lobodzinski S, Anton-Culver H, Manolio T. Echocardiographic design of a multi-center investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr. 1992;5:63-72.
30. Cushman M, Cornell E, Howard P, Bovill E, Tracy R. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
31. WHO expert committee on diabetes mellitus: second report. Geneva, Switzerland: World Health Organization; World Health Organization Technical Report Series 646. 1980.
32. Newman A, Siscovick D, Manolio T, Polak J, Fried L, Borhani N, Wolfson S, for the CHS Investigators. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845.
33. Seligsohn U, Osterud B, Griffin J, Rapaport S. Evidence for the participation of both activated factor XII and activated factor IX in the cold promoted-activation of factor VII. Thromb Res. 1978;13: 1049-1056.
34. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-501.
35. Clauss A. Gerinnungs-physiologische schnell-methode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237-246.
36. Barrowcliffe T. Standardization of factors II, VII, IX, X in plasma and concentrates. Thromb Haemost. 1988;59:334.
37. Barrowcliffe T. Standardization of assays for factor VIII and factor IX. Ricerca Clin E Laboratorio. 1990;20:155-165.
38. SPSS/PC+ V2.0. Chicago, Ill: SPSS Inc; 1988.
39. Fischer C, Gill C. Acute-phase proteins. In: Ritzmann S, Daniels J, eds. Serum Protein Abnormalities: Diagnostic and Clinical Aspects. Boston, Mass: Little, Brown and Co; 1975:331-350.
40. Meade T, Vickers M, Thompson S, Seghatchian M. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res. 1985;38:527-534.
41. Naski M, Shafer J. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III. J Biol Chem. 1991;266:13003-13010.
42. Letcher R, Chien S, Pickering T, Laragh J. Elevated blood viscosity in patients with borderline hypertension. Hypertension. 1983;5:757-762.
43. Smith E, Keen G, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis. 1990;10:263-275.
44. Smith E. Fibrinogen, fibrin, fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986;15:355-370.
45. Tracy R, Bovill E. Hemostasis and risk of ischemic disease: epidemiologic evidence with emphasis on the elderly. In: Califf R, Mark D, Wagner G, eds. Acute Coronary Care in the Thrombolytic Era. St Louis, Mo: Mosby-Year Book Inc; 1995:27-43.
46. Hamsten A, Iselius L, DeFaire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet. 1987;2:988-991.
47. Humphries S, Cook M, Dubowitz M, Stirling Y, Meade T. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1:1452-1455.
48. Berg K, Kierulf P. DNA polymorphisms at the fibrinogen loci and plasma fibrinogen concentration. Clin Genet. 1989;36:229-235.
49. Reed T, Tracy R, Fabsitz R. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clin Genet. 1994;45:71-77.
50. Aronow W, Schoenfeld M. Forty-five month follow-up of extracranial carotid arterial disease for new coronary events in elderly patients. Coron Artery Dis. 1992;3:249-251.
51. Tracy R, Psaty B, Bovill E, Fried L, Heiss G, Lee M, Polak J, Savage P, for the CHS Investigators. Fibrinogen and factor VIII. but not factor VII, are positively associated with prevalent cardiovascular disease in older adults: analyses from the Cardiovascular Health Study. 32nd Annual Conference on Cardiovascular Disease Epidemiology. 1992.
52. Folsom A, Wu K, Shahar E, Davis C. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb. 1993;13:1829-1836.
53. Wu K, Folsom A, Heiss G, Davis C, Conlon M, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis: early results of the Atherosclerosis Risk in Communities (ARIC) study. Ann Epidemiol. 1992;2:471-480.
54. Tell G, Howard G, McKinney W. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound. J Clin Epidemiol. 1989;42:551-559.
55. Solberg L, Eggen D. Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation. 1971;43:711-724.
56. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-128.
57. Criqui M, Langer R, Fronek A, Feigelson H, Klauber M, McCann T, Browner D. Mortality over a period of ten years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
58. Ernst E, Resch K. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993; 118:956-963.
59. Letcher R, Chien S, Pickering T, Sealey J, Laragh J. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and concentration. Am J Med. 1981;70:1195-1202.
60. Hoffman C, Miller R, Lawson W, Hultin M. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol. 1989;14:941-946.
61. Bruckert E, Carvalho de Sousa J, Giral P, Soria C, Chapman M, Caen J, de Gennes J-L. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis. 1989;75:129-134.
62. Orlando M, Leri O, Macioce G, Mattia G, Ferri G. Factor VII in subjects at risk for thromboembolism: activation or increased synthesis? Haemostasis. 1987;17:340-343.
63. Hayes T, Pike J, Tracy R. Factor VII assays. Arch Pathol Lab Med. 1993;117:52-57.
64. Miller G, Stirling Y, Esnouf M, Heinrich J, van der Loo J, Kienast J, Wu K, Morrissey J, Meade T, Martin J, Imeson J, Cooper J, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost. 1994;71:38-48.
65. Marckmann P, Sandstrom B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb. 1993;13:505-511.
66. Miller G, Martin J, Webster J, Wilkes H, Miller N, Wilkinson W, Meade T. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:269-277.
67. Miller G, Martin J, Mitropoulos K, Reeves B, Thompson R, Meade T, Cooper J, Cruickshank J. Plasma factor VII is activated by postprandial triglyceridemia, irrespective of dietary fat composition. Atherosclerosis. 1991;86:163-171.
68. Mitropoulos K, Miller G, Martin J, Reeves B, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb. 1994; 14:214-222.
69. Meade T, Chakrabarti R, Haines A, North W, Stirling Y, Thompson S. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1054.
70. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, della Volpe A, Polli E, Group PS. The PLAT study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients - principal results. Arterioscler Thromb. 1992;12:1063-1070.